First Time Loading...

Adaptive Biotechnologies Corp
NASDAQ:ADPT

Watchlist Manager
Adaptive Biotechnologies Corp Logo
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Watchlist
Price: 2.93 USD 5.02% Market Closed
Updated: May 3, 2024

Adaptive Biotechnologies Corp
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Adaptive Biotechnologies Corp
Cash from Operating Activities Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Cash from Operating Activities
-$156.3m
CAGR 3-Years
-1%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Cash from Operating Activities
$8.4B
CAGR 3-Years
0%
CAGR 5-Years
13%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Cash from Operating Activities
$7B
CAGR 3-Years
-1%
CAGR 5-Years
12%
CAGR 10-Years
7%
Mettler-Toledo International Inc
NYSE:MTD
Cash from Operating Activities
$965.9m
CAGR 3-Years
10%
CAGR 5-Years
11%
CAGR 10-Years
11%
Agilent Technologies Inc
NYSE:A
Cash from Operating Activities
$2B
CAGR 3-Years
17%
CAGR 5-Years
13%
CAGR 10-Years
6%
IQVIA Holdings Inc
NYSE:IQV
Cash from Operating Activities
$2.1B
CAGR 3-Years
3%
CAGR 5-Years
11%
CAGR 10-Years
19%

See Also

What is Adaptive Biotechnologies Corp's Cash from Operating Activities?
Cash from Operating Activities
-156.3m USD

Based on the financial report for Dec 31, 2023, Adaptive Biotechnologies Corp's Cash from Operating Activities amounts to -156.3m USD.

What is Adaptive Biotechnologies Corp's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
-37%

Over the last year, the Cash from Operating Activities growth was 15%. The average annual Cash from Operating Activities growth rates for Adaptive Biotechnologies Corp have been -1% over the past three years , -37% over the past five years .